Ratings by Barclays (Luke Sergott)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/14/2021 Sotera Health SHC Maintain Overweight
(N/A)
 
 
  Details
5/7/2021 Certara Inc. CERT Maintain Overweight
(N/A)
 
 
  Details
4/30/2021 Syneos SYNH Maintain Equalweight
(N/A)
 
 
  Details
4/29/2021 Avantor Inc. AVTR Maintain Overweight
(N/A)
 
 
  Details
4/26/2021 IQVIA Holdings IQV Maintain Overweight
(N/A)
 
 
  Details
4/26/2021 Danaher DHR Maintain Overweight
(N/A)
 
 
  Details
3/3/2021 Thermo Fisher Scientific TMO New Coverage Overweight
(N/A)
459.56
(496.40)
8.02% Details
3/3/2021 Syneos SYNH New Coverage Equalweight
(N/A)
76.33
(87.16)
14.19% Details
3/3/2021 Sotera Health SHC New Coverage Overweight
(N/A)
27.60
(24.23)
-12.21% Details
3/3/2021 PPD Inc. PPD New Coverage Overweight
(N/A)
35.52
(46.18)
30.01% Details
3/3/2021 Ortho Clinical Diagnostics OCDX New Coverage Overweight
(N/A)
17.59
(21.72)
23.48% Details
3/3/2021 IQVIA Holdings IQV New Coverage Overweight
(N/A)
194.39
(243.19)
25.1% Details
3/3/2021 ICON plc ICLR New Coverage Equalweight
(N/A)
173.00
(217.41)
25.67% Details
3/3/2021 Illumina ILMN New Coverage Underweight
(N/A)
446.50
(468.77)
4.99% Details
3/3/2021 Danaher DHR New Coverage Overweight
(N/A)
225.67
(269.08)
19.24% Details
3/3/2021 Certara Inc. CERT Maintain Overweight
(N/A)
 
 
  Details
3/3/2021 Avantor Inc. AVTR New Coverage Overweight
(N/A)
28.47
(35.30)
23.99% Details